Synthesis of norbornenyl polymers with bioactive oligopeptides by ring-opening metathesis polymerization

Macromolecules

Volumn 33, Issue 17, 2000, Pages 6239-6248

  Maynard, Heather D ^a   Okada, Sheldon Y ^a   Grubbs, Robert H ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOSITION EFFECTS; GLASS TRANSITION; INITIATORS (CHEMICAL); MOLECULAR STRUCTURE; MOLECULAR WEIGHT DISTRIBUTION; MONOMERS; OLIGOMERS; POLYPEPTIDES; RING OPENING POLYMERIZATION; RUTHENIUM; SYNTHESIS (CHEMICAL);

OLIGOPEPTIDES;

AROMATIC POLYMERS;

EID: 0034702667     PISSN: 00249297     EISSN: None     Source Type: Journal    
DOI: 10.1021/ma000460c     Document Type: Article

References (35)

1. For reviews see: (a) Ruoslahti, E.; Pierschbacher, M. D. Science 1987, 238, 491-497. (b) Ruoslahti, E. Annu. Rev. Cell Dev. Biol. 1996, 12, 697-715.
2. For reviews see: (a) Ruoslahti, E.; Pierschbacher, M. D. Science 1987, 238, 491-497. (b) Ruoslahti, E. Annu. Rev. Cell Dev. Biol. 1996, 12, 697-715.
3. For reviews see: (a) Pierschbacher, M. D.; Polarek, J. W.; Craig, W. S.; Tschopp, J. F.; Sipes, N. J.; Harper, J. R. J. Cell. Biochem. 1994, 56, 150-154. (b) Ojima, I.; Chakravarty, S.; Dong, Q. Bioorg. Med. Chem. 1995, 3, 337-360.
4. For reviews see: (a) Pierschbacher, M. D.; Polarek, J. W.; Craig, W. S.; Tschopp, J. F.; Sipes, N. J.; Harper, J. R. J. Cell. Biochem. 1994, 56, 150-154. (b) Ojima, I.; Chakravarty, S.; Dong, Q. Bioorg. Med. Chem. 1995, 3, 337-360.
5. For reviews see: (a) Akiyama, S. K.; Olden, K.; Yamada, K. M. Cancer Metastasis Rev. 1995, 14, 173-189. (b) Ruoslahti, E. Adv. Cancer Res. 1999, 1-20.
6. For reviews see: (a) Akiyama, S. K.; Olden, K.; Yamada, K. M. Cancer Metastasis Rev. 1995, 14, 173-189. (b) Ruoslahti, E. Adv. Cancer Res. 1999, 1-20.
7. This has been shown for polypeptides containing multiple RGDs. For a review of these materials, see: Saiki, I. Jpn. J. Pharmacol. 1997, 75, 215-242.
8. Aota, S.; Nomizu, M.; Yamada, K. M. J. Biol. Chem. 1994, 269, 24756-24761.
9. Komazawa, H.; Saiki, I.; Igarashi, Y.; Azuma, I.; Kojima, M.; Orikasa, A.; Ono, M.; Itoh, I. J. Bioact. Compat. Polym. 1993, 8, 258-274.
10. For an example, see: Maynard, H. D.; Grubbs, R. H. Macromolecules 1999, 32, 6917-6924.
11. For examples, see: (a) Manning, D. D.; Hu, X.; Beck, P.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 3161-3162. (b) Kanai, M.; Mortell, K. H.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 9931-9932 (c) Strong, L. E.; Kiessling, L. L. J. Am. Chem. Soc. 1999, 121, 6193-6196.
12. For examples, see: (a) Manning, D. D.; Hu, X.; Beck, P.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 3161-3162. (b) Kanai, M.; Mortell, K. H.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 9931-9932 (c) Strong, L. E.; Kiessling, L. L. J. Am. Chem. Soc. 1999, 121, 6193-6196.
13. For examples, see: (a) Manning, D. D.; Hu, X.; Beck, P.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 3161-3162. (b) Kanai, M.; Mortell, K. H.; Kiessling, L. L. J. Am. Chem. Soc. 1997, 119, 9931-9932 (c) Strong, L. E.; Kiessling, L. L. J. Am. Chem. Soc. 1999, 121, 6193-6196.
14. Deletion studies have determined that R is the important residue for PHSRN function, suggesting that this sequence could be further truncated to SRN, yet still retain its synergistic activity (see ref 5). Therefore, for simplicity, small peptides were chosen. However the polymers can be synthesized using the same approach with larger pendent peptides such as GRGDS and PHSRN.
15. For example, see: Prime, K. L.; Whitesides, G. M. J. Am. Chem. Soc. 1993, 115, 10714-10721 and references therein.
16. (a) Coles, M. P.; Gibson, V. C.; Mazzariol, L.; North, M.; Teasdale, W. G.; Williams, C. M.; Zamuner, D. J. Chem Soc., Chem. Commun. 1994, 2505-2506.
17. (b) Biagini, S. C. G.; Coles, M. P.; Gibson, V. C.; Giles, M. R.; Marshall, E. L.; North, M. Polymer 1998, 39, 1007-1014.
18. (c) Biagini, S. C. G.; Davies, R. G.; Gibson, V. C.; Giles, M. R.; Marshall, E. L.; North, M.; Robson, D. A. Chem. Commun. 1999, 235-236.
19. (a) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. Chem., Int. Ed. Engl. 1995, 34, 2039-2041.
20. (b) Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 100-110.
21. (a) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
22. (b) Chatterjee, A. K.; Grubbs, R. H. Org. Lett. 1999, 1, 1751-1753.
23. (c) Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 3783-3784.
24. Heated in 1,2-dichlorobenzene to 185°C, see: Craig, D. J. Am. Chem. Soc. 1951, 73, 4889-4892.
25. Biagini, S. C. G.; Bush, S. M.; Gibson, V. C.; Mazzariol, L.; North, M.; Teasdale, W. G.; Williams, C. W.; Zagotto, G.; Zamuner, D. Tetrahedron 1995, 51, 7247-7262.
26. Poly(15) and poly(16) have been synthesized by Baigini, et al. (ref 11a,b) using molybdenum catalysts; since ruthenium initiators were used in our study, the synthesis and characterization of these polymers using 1 as the initiator is included here.
27. Leahy, D. J.; Aukhil, I.; Erickson, H. P. Cell 1996, 84, 155-164.
28. This is thought to be due to unfavorable steric interactions between the monomer and initiating species; see ref 11b.
29. Andrews, R. J.; Grulke, E. A. In Polymer Handbook, 4th ed.; Brandrup, J., Immergut, E. H., Grulke, E. A., Eds.; Wiley-Interscience: New York, 1999; p VI/208.
30. Maughon, B. R.; Grubbs, R. H. Macromolecules 1997, 30, 3459-3469.
31. Bielawski, C. W.; Grubbs, R. H. Angew. Chem., Int. Ed. 2000, in press.
32. Catalyst 1 is markedly less active than 2 and 3 at higher temperatures and is less stable at higher temperatures (see ref 21). For this reason, polymerizations with 1 were conducted at room temperature, while those with 2 and 3 were conducted at 55°C.
33. This method could not be used with the other protected polymers due to the insolubility of these polymers in solvents suitable for centrifugation through the membrane.
34. Ver Nooy, C. D.; Rondestvedt, C. S., Jr. J. Am. Chem. Soc. 1955, 77, 7, 3583-3586.
35. Stille, J. R.; Santarsiero, B. D.; Grubbs, R. H. J. Org. Chem. 1990, 55, 843-862.